Provided by Tiger Trade Technology Pte. Ltd.

Annovis Bio, Inc.

1.12
-0.0700-5.88%
Post-market: 1.150.0304+2.71%19:43 EDT
Volume:1.89M
Turnover:2.17M
Market Cap:47.65M
PE:-0.63
High:1.23
Open:1.20
Low:1.10
Close:1.19
52wk High:5.50
52wk Low:1.10
Shares:42.54M
Float Shares:35.32M
Volume Ratio:0.68
T/O Rate:5.36%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.7895
EPS(LYR):-1.4040
ROE:-703.68%
ROA:-142.36%
PB:-11.20
PE(LYR):-0.80

Loading ...

Top Insider Makes Bold Multi-Million Dollar Move Into Annovis Bio

TIPRANKS
·
Apr 04

Annovis Bio director Michael B. Hoffman buys $1.5 million common shares

Reuters
·
Apr 04

Annovis Bio wins U.S. patent for buntanetap to treat brain infection-related injuries

Reuters
·
Apr 02

Annovis Publishes Historical Review of Buntanetap in The Scientist

GlobeNewswire
·
Mar 31

Annovis Bio Inc - CEO Maria Maccecchini to Serve as Acting CFO Until Replacement Is Identified - SEC Filing

THOMSON REUTERS
·
Mar 26

Annovis Bio Inc - Mark Guerin Steps Down as CFO Effective March 23, 2026 - SEC Filing

THOMSON REUTERS
·
Mar 26

Annovis Bio CFO Mark Guerin departs; CEO Maria Maccecchini becomes acting CFO effective March 23, 2026

Reuters
·
Mar 26

Annovis Bio enters partnership with NeuroRPM

TIPRANKS
·
Mar 19

Annovis Bio partners with NeuroRPM for AI wearable monitoring in Parkinson’s trial

Reuters
·
Mar 19

Annovis Bio partners with NeuroRPM to deploy FDA-cleared AI digital biomarkers in Parkinson’s study

Reuters
·
Mar 19

Neurorpm to Deploy AI-Enabled Digital Biomarker Monitoring for Annovis Bio's Parkinson's Disease Clinical Trial

THOMSON REUTERS
·
Mar 19

Analysts Offer Insights on Healthcare Companies: Warby Parker (WRBY) and Annovis Bio (ANVS)

TIPRANKS
·
Mar 19

BRIEF-Annovis Provides Corporate Updates And Reports Fiscal Year 2025 Financial Results

Reuters
·
Mar 16

Annovis Bio reports FY25 EPS ($1.40) vs. ($2.31) last year

TIPRANKS
·
Mar 16

Annovis Bio Q4 EPS $(0.39) Misses $(0.34) Estimate

Benzinga Earnings
·
Mar 16

Annovis Bio Inc: Estimates That Its Current Cash and Cash Equivalents Will Enable It to Fund Its Operations Into Q3 of 2026

THOMSON REUTERS
·
Mar 16

Press Release: Annovis Provides Corporate Updates and Reports Fiscal Year 2025 Financial Results

Dow Jones
·
Mar 16